Obligation Citi Global Markets Finance 0% ( XS1676912345 ) en USD

Société émettrice Citi Global Markets Finance
Prix sur le marché 100 %  ⇌ 
Pays  Luxembourg
Code ISIN  XS1676912345 ( en USD )
Coupon 0%
Echéance 11/11/2022 - Obligation échue



Prospectus brochure de l'obligation Citigroup Global Markets Funding XS1676912345 en USD 0%, échue


Montant Minimal 1 000 USD
Montant de l'émission 500 000 USD
Description détaillée Citigroup Global Markets Funding est une division de Citigroup qui fournit des services de financement aux marchés mondiaux, notamment le financement de titres, le financement de prêts et d'autres solutions de financement pour les institutions financières et les entreprises.

L'Obligation émise par Citi Global Markets Finance ( Luxembourg ) , en USD, avec le code ISIN XS1676912345, paye un coupon de 0% par an.
Le paiement des coupons est semestriel et la maturité de l'Obligation est le 11/11/2022







Pricing Supplement dated 24 January 2018
Citigroup Global Markets Funding Luxembourg S.C.A.

Issue of USD 200,000 Capital at Risk Growth Notes due November 2022 linked to the
STOXX® 600 Health Care (Price) Index (to be consolidated and form a single Series with
the USD500,000 Capital at Risk Growth Notes due November 2022 linked to the STOXX®
600 Health Care (Price) Index (the Original Notes))

Guaranteed by Citigroup Global Markets Limited

Under the Citi U.S.$30,000,000,000 Global Medium Term Note Programme

No prospectus is required in accordance with the Prospectus Directive (as defined
below) in relation to Notes which are the subject of this Pricing Supplement.
THE NOTES ARE ISSUED AT A SIGNIFICANT DISCOUNT TO PAR. NO
INTEREST WILL BE PAYABLE UNDER THE NOTES. THE REDEMPTION
AMOUNT ON THE MATURITY DATE COULD BE SUBSTANTIALLY BELOW
THE ISSUE PRICE AND MAY EVEN BE AS LOW AS USD0.00
The Offering Circular referred to below (as completed by this Pricing Supplement) has been
prepared on the basis that any offer of Notes in any Member State of the European Economic
Area which has implemented the Prospectus Directive (each, a Relevant Member State) will
be made pursuant to an exemption under the Prospectus Directive, as implemented in that
Relevant Member State, from the requirement to publish a prospectus for offers of the Notes.
Accordingly any person making or intending to make an offer in that Relevant Member State
of the Notes may only do so in circumstances in which no obligation arises for the Issuer or
any Dealer to publish a prospectus pursuant to Article 3 of the Prospectus Directive or
supplement a prospectus pursuant to Article 16 of the Prospectus Directive, in each case, in
relation to such offer. None of the Issuer, the CGMFL Guarantor and any Dealer has
authorised, nor does any of them authorise, the making of any offer of Notes in any other
circumstances. For the purposes herefor, the expression Prospectus Directive means
Directive 2003/71/EC (as amended, including by Directive 2010/73/EU), and any relevant
implementing measure in a Relevant Member State.
The Notes and the CGMFL Deed of Guarantee have not been and will not be registered under
the United States Securities Act of 1933, as amended (the Securities Act) or any state
securities law. The Notes are being offered and sold outside the United States to non-U.S.
persons in reliance on Regulation S under the Securities Act (Regulation S) and may not be
offered or sold within the United States or to, or for the account or benefit of, any U.S. person
(as defined in Regulation S). Each purchaser of the Notes or any beneficial interest therein
will be deemed to have represented and agreed that it is outside the United States and is not a
U.S. person and will not sell, pledge or otherwise transfer the Notes or any beneficial interest
therein at any time within the United States or to, or for the account or benefit of, a U.S.
person, other than the Issuer or any affiliate thereof. For a description of certain restrictions
on offers and sales of Notes, see "Subscription and sale and transfer and selling restrictions
for Notes" of the Offering Circular and item 5 of Part B below.
The Notes and the CGMFL Deed of Guarantee do not constitute, and have not been marketed
as, contracts of sale of a commodity for future delivery (or options thereon) subject to the
United States Commodity Exchange Act, as amended, and trading in the Notes has not been
approved by the United States Commodity Futures Trading Commission under the United
States Commodity Exchange Act, as amended.

1

CGMFL2253





The Notes may not be offered or sold to, or acquired by, any person that is, or whose purchase
and holding of the Notes is made on behalf of or with "plan assets" of, an employee benefit
plan subject to Title I of the U.S. Employee Retirement Income Security Act of 1974, as
amended (ERISA), a plan, individual retirement account or other arrangement subject to
Section 4975 of the U.S. Internal Revenue Code of 1986, as amended (the Code) or an
employee benefit plan or plan subject to any laws, rules or regulations substantially similar to
Title I of ERISA or Section 4975 of the Code.

PART A ­ CONTRACTUAL TERMS

The Notes are English Law Notes that are also Registered Notes. The Notes are issued under
the Offering Circular as defined below.
Terms used herein shall be deemed to be defined as such for the purposes of the Conditions
set forth under the sections entitled "General Conditions of the Notes", and the Underlying
Schedule applicable to the Underlying in the Offering Circular.
This document constitutes the Pricing Supplement of the Notes described herein and must be
read in conjunction with the Offering Circular. Full information on the Issuer, the CGMFL
Guarantor and the offer of the Notes is only available on the basis of the combination of this
Pricing Supplement and the Offering Circular.

The Offering Circular (including all documents incorporated by reference therein) is available
for viewing at the offices of the Fiscal Agent and the Paying Agents.
For the purposes hereof, Offering Circular means the Offering Circular dated 15 December
2017 in relation to the Programme including all documents incorporated by reference therein.
1.
(i)
Issuer:
Citigroup
Global
Markets
Funding
Luxembourg S.C.A

(ii)
Guarantor:
Citigroup Global Markets Limited
2.
(i)
Series Number:
CGMFL2253 A

(ii)
Tranche Number:
2

(iii)
Date on which the Notes will be The Notes will be consolidated and form a
consolidated and form a single single Series with the Original Notes on the
Series:
Issue Date
3.
Specified Currency or Currencies:
United States dollars (USD)
4.
Aggregate Principal Amount:


(i)
Series:
USD 700,000

(ii)
Tranche:
Tranche 1: USD 500,000 (the Original
Notes)
Tranche 2: USD 200,000 (the Fungible
Notes and together with the Original
Notes, the Notes)


2

CGMFL2253





5.
Issue Price:
11.88per cent of the Aggregate Principal
Amount of Tranche 2
6.
(i)
Specified Denominations:
USD1,000

(ii)
Calculation Amount:
USD1,000
7.
(i)
Issue Date:
29 January 2018

(ii)
Interest Commencement Date:
Not Applicable
8.
Maturity Date:
11 November 2022
9.
Types of Notes:
(i)
Underlying Linked Notes


(ii)
The Notes are Underlying linked
Notes
and
relate
to
the
Underlying(s) specified in item
16(i) below


(iii)
The Notes are Cash Settled Notes
10.
Interest Basis:
The Notes do not bear or pay any interest
11.
Redemption/Payment Basis
Underlying Linked Redemption
12.
Change of Interest or
Not Applicable
Redemption/Payment Basis:
13.
Put/Call Options:
Not Applicable
14.
(i)
Status of the Notes:
Senior

(ii)
Status of the CGMFL Deed of Senior
Guarantee, as applicable:
15.
Method of Distribution:
Non-syndicated
PROVISIONS RELATING TO UNDERLYING LINKED NOTES
16.
Underlying Linked Notes Provisions:
Applicable ­ the provisions in Condition
19 of the General Conditions apply
(subject as provided in the relevant
Underlying Schedule)

(i)
Underlying:


(A)
Description of
STOXX® 600 Health Care (Price) Index

Underlying(s):

(B)
Classification:
Security Index

(C)
Electronic Page:
Bloomberg page: SXDP <Index>

3

CGMFL2253






(ii)
Particulars in respect of each
Underlying:

Security Index/Indices:


(A)
Type of Index:
Multiple Exchange Index

(C)
Related Exchange(s):
All Exchanges

(D)
Single Valuation Time:
Not Applicable

(E) Same Day Publication:
Applicable

(iii)
Elections in respect of each type
of Underlying:

Security Index / Indices:


(A)
Additional
Disruption Increased Cost of Stock Borrow
Event(s):

Loss of Stock Borrow

(iv)
Trade Date:
18 January 2018

(v)
Realisation Disruption:
Not Applicable

(vi)
Hedging Disruption Early
Not Applicable
Termination Event:
PROVISIONS RELATING TO INTEREST (IF ANY) PAYABLE
17.
Fixed Rate Note Provisions
Not Applicable
18.
Floating Rate Note Provisions
Not Applicable
19.
Zero Coupon Note Provisions
Not Applicable
20.
Dual Currency Interest Provisions
Not Applicable
21.
Underlying Linked Notes Interest Not Applicable
Provisions
PROVISIONS RELATING TO REDEMPTION
22.
Issuer Call
Not Applicable
23.
Investor Put
Not Applicable
24.
Redemption
Amount
of
each See item 25 below and the Schedule
Calculation Amount
attached hereto
25.
Underlying Linked Notes Redemption Applicable
Provisions

(i)
Redemption Amount for
See paragraph 1 of the Schedule attached
Underlying Linked Notes:
hereto

(ii)
Specified Valuation Date(s):
24 October 2022. Such date shall be
subject to adjustment as provided in

4

CGMFL2253





Condition 19 of the General Conditions
(such Valuation Date, as so adjusted, the
Final Valuation Date)

(iii)
Valuation Disruption (Scheduled Condition 19(c)(i) of the General
Trading Days):
Conditions applies

(iv)
Valuation Disruption (Disrupted Condition 19(d)(i) of the General
Days):
Conditions applies

(v)
Valuation Roll:
Eight
26.
Mandatory
Early
Redemption Not Applicable
Provisions
27.
Early Redemption Amount


(i)
Early Redemption Amount(s) Condition 5(d)(iii)(A) of the General
payable
on
redemption
for Conditions applies
taxation reasons or illegality
(Condition 5(b) of the General
Conditions) or on Event of
Default (Condition 9 of the
General Conditions) or other
relevant
early
redemption
pursuant to the Conditions and/or
the method of calculating the
same:

(ii)
Early
Redemption
Amount Not Applicable
includes amount in respect of
accrued interest:
28.
Provisions
applicable
to
Physical Not Applicable
Delivery
29.
Variation of Settlement


(i)
Issuer's or Intermediary's option Not Applicable
to vary settlement

(ii)
Holder's
option
to
vary Not Applicable
settlement:
GENERAL PROVISIONS APPLICABLE TO THE NOTES
30.
Form of Notes:
Registered Notes
Regulation S Global Registered Note
Certificate registered in the name of a
nominee for a common depositary for
Euroclear and Clearstream, Luxembourg
31.
Governing Law:
English law applies
32.
New Safekeeping Structure:
Not Applicable

5

CGMFL2253





33.
Business Centres:
London and New York City
34.
Business Day Jurisdiction(s) or other London and New York City
special provisions relating to payment
dates:
35.
Renminbi Settlement Centre(s):
Not Applicable
36.
Details relating to Partly Paid Notes: Not Applicable
amount of each payment comprising the
Issue Price and date on which each
payment is to be made and consequences
(if any) of failure to pay, including any
right of the Issuer to forfeit the Notes and
interest due on late payment:
37.
Details relating to Instalment Notes: Not Applicable
amount of each Instalment Amount
(including any maximum or minimum
Instalment Amount), date on which each
payment is to be made:
38.
Redenomination, renominalisation and Not Applicable
reconventioning provisions:
39.
Consolidation provisions:
The provisions of Condition 12 of the
General Conditions apply
40.
Other terms and conditions:
See the Schedule attached hereto
41.
Name and address of Calculation Agent:
Citigroup Global Markets Limited of 33
Canada Square, London, E14 5LB, acting
through its Stocks Exotic Trading Desk
in
London
(or
any
successor
department/group)

42.
Determinations:
Sole and Absolute Determination




6

CGMFL2253





PURPOSE OF PRICING SUPPLEMENT
This Pricing Supplement comprises the Pricing Supplement required for the issue and
admission to trading on the Luxembourg Stock Exchange's Euro MTF Market of the Notes
described herein pursuant to the Citi U.S.$30,000,000,000 Global Medium Term Note
Programme of Citigroup Inc., Citigroup Global Markets Holdings Inc., Citigroup Global
Markets Funding Luxembourg S.C.A. and Citigroup Global Markets Limited.
RESPONSIBILITY
The Issuer and the CGMFL Guarantor accept responsibility for the information contained in
this Pricing Supplement. Information relating to the Security Index has been extracted from
the Bloomberg pages. Each of the Issuer and the CGMFL Guarantor confirms that such
information has been accurately reproduced and that, so far as it is aware and is able to
ascertain from such sources, no facts have been omitted which would render the reproduced
information inaccurate or misleading.

Signed on behalf of the Issuer:

By:
..........................................
Duly authorised



7

CGMFL2253





PART B ­ OTHER INFORMATION
1.
LISTING AND ADMISSION TO TRADING

Listing and admission to Application has been made by the Issuer (or on its
trading:
behalf) for the Tranche 2 Notes to be admitted to
the Official List and to trading on the Luxembourg
Stock Exchange's Euro MTF Market with effect
from or around the Issue Date of the Tranche 2
Notes.
The Original Notes issued on 13 November 2017
are listed on the Official List and admitted to
trading on the Eruo MTF Market of the
Luxembourg Stock Exchange with effect from 13
November 2017.

2.
RATINGS

Ratings:
The Notes are not rated
3.
REASONS FOR THE ISSUE AND ESTIMATED NET PROCEEDS

(i) Reasons for the issue:
See "Use of Proceeds" in the description of the
Issuer in the Offering Circular

(ii) Estimated net proceeds:
USD 23,760
4.
PERFORMANCE OF THE UNDERLYING(S), EXPLANATION OF EFFECT
ON VALUE OF INVESTMENT AND ASSOCIATED RISKS AND OTHER
INFORMATION CONCERNING THE UNDERLYING(S)
The Notes are linked to the performance of the STOXX® 600 Health Care (Price)
Index
The Redemption Amount in respect of each Calculation Amount shall be an amount
in USD equal to the Calculation Amount multiplied by the percentage change in the
underlying performance since the Strike Date, floored at 0%. The underlying
performance is determined as the official closing level of the Underlying on the
Final Valuation Date divided by its official closing level on the Strike Date. The past
and further performance of the Underlying can be obtained from the Electronic Page
specified for such Underlying in the Schedule attached hereto.
5.
UNDERLYING DISCLAIMER


STOXX® 600 Health Care (Price) Index
STOXX Limited (STOXX) and its licensors (the Licensors) have no relationship to
the Issuer or the Dealer, other than the licensing of the STOXX® 600 Health Care
(Price) Index (the SXDP Index) and the related trademarks for use in connection
with the Notes.

8

CGMFL2253





STOXX and its Licensors do not:

Sponsor, endorse, sell or promote the Notes.

Recommend that any person invest in the Notes or any other securities.

Have any responsibility or liability for or make any decisions about the
timing, amount or pricing of the Notes.

Have any responsibility or liability for the administration, management or
marketing of the Notes.
Consider the needs of the Notes or the owners of the Notes in determining,
composing or calculating the SXDP Index or have any obligation to do so.
STOXX and its Licensors will not have any liability in connection with the
Notes. Specifically,
·
STOXX and its Licensors do not make any warranty, express or
implied and disclaim any and all warranty about:
·
The results to be obtained by the Notes, the owners of the Notes or any
other person in connection with the use of the SXDP Index and the data
included in the SXDP Index;
·
The accuracy or completeness of the SXDP Index and its data;
·
The merchantability and the fitness for a particular purpose or use of
the SXDP Index and its data;
·
STOXX and its Licensors will have no liability for any errors, omissions
or interruptions in the SXDP Index or its data;
Under no circumstances will STOXX or its Licensors be liable for any lost
profits or indirect, punitive, special or consequential damages or losses, even if
STOXX or its Licensors knows that they might occur.

Bloomberg®

Certain information contained in this Pricing Supplement consists of extracts from
or summaries of information that is publicly-available from Bloomberg L.P.
(Bloomberg®). The Issuer and the CGMFL Guarantor accept responsibility for
accurately reproducing such extracts or summaries and, as far as the Issuer and the
CGMFL Guarantor are aware and are able to ascertain from such publicly-available
information, no facts have been omitted which would render the reproduced
information inaccurate or misleading. Bloomberg® makes no representation,
warranty or undertaking, express or implied, as to the accuracy of the reproduction
of such information, and accepts no responsibility for the reproduction of such
information or for the merits of an investment in the Notes. Bloomberg® does not
arrange, sponsor, endorse, sell or promote the issue of the Notes.
6.
OPERATIONAL INFORMATION

ISIN Code:
XS1676912345

9

CGMFL2253






Common Code:
167691234

Any clearing system(s) other than Not Applicable
Euroclear, Clearstream Luxembourg
and
DTC
and
the
relevant
identification number(s) and details
relating to the relevant depositary, if
applicable:

Delivery:
Delivery versus payment

Names and address of the Swedish Not Applicable
Notes Issuing and Paying Agent (if
any):

Names and address of the Finnish Not Applicable
Notes Issuing and Paying Agent (if
any):

Names and address of additional Not Applicable
Paying Agent(s) (if any):

Intended to be held in a manner which Not Applicable
would allow Eurosystem eligibility:
7.
DISTRIBUTION

If syndicated, names and addresses of Not Applicable
Managers
and
underwriting
commitments:

Date of Subscription Agreement:
Not Applicable

Stabilising Manager(s) (if any):
Not Applicable

If non-syndicated, name and address of Citigroup Global Markets Limited at
Dealer:
Citigroup Centre, Canada Square, Canary
Wharf, London E14 5LB, United Kingdom

Total commission and concession:
No commissions and concessions are
payable by the Issuer to the Dealer
The Distribution fee payable by the Dealer
to any distributor is 1.4% of the Aggregate
Principal Amount.
Investors can obtain more information
about the fee by contacting the Dealer at
the address set out above.

Additional selling restrictions:
Not Applicable

10

CGMFL2253